These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 8170138

  • 21. L-364,718, a new CCK antagonist, inhibits postprandial pancreatic secretion and PP release in dogs.
    Hosotani R, Chowdhury P, Rayford PL.
    Dig Dis Sci; 1989 Mar; 34(3):462-7. PubMed ID: 2646088
    [Abstract] [Full Text] [Related]

  • 22. Octreotide and cholecystokinin antagonist reduce edema in obstruction-induced acute pancreatitis.
    Toriumi Y, Samuel I, Wilcockson DP, Turkelson CM, Solomon TE, Joehl RJ.
    J Lab Clin Med; 1993 Oct; 122(4):450-4. PubMed ID: 8228560
    [Abstract] [Full Text] [Related]

  • 23. Evidence for vagus-dependent pancreatic polypeptide-releasing factor in the antrum: studies with the autotransplanted dog pancreas.
    Debas HT, Taylor IL, Seal AM, Passaro EP.
    Surgery; 1982 Aug; 92(2):309-14. PubMed ID: 7048599
    [Abstract] [Full Text] [Related]

  • 24. Pancreatic polypeptide release: role of stimulants of exocrine pancreatic secretion in dogs.
    Beglinger C, Taylor IL, Grossman MI, Solomon TE.
    Gastroenterology; 1984 Sep; 87(3):530-6. PubMed ID: 6146550
    [Abstract] [Full Text] [Related]

  • 25. Mechanism of actions of cholecystokinin octapeptide on food intake and insulin and pancreatic polypeptide release in the dog.
    Inui A, Okita M, Inoue T, Sakatani N, Oya M, Morioka H, Ogawa T, Mizuno N, Baba S.
    Peptides; 1988 Sep; 9(5):1093-100. PubMed ID: 3072534
    [Abstract] [Full Text] [Related]

  • 26. Regulation of pancreatic endocrine function by cholecystokinin: studies with MK-329, a nonpeptide cholecystokinin receptor antagonist.
    Liddle RA, Gertz BJ, Kanayama S, Beccaria L, Gettys TW, Taylor IL, Rushakoff RJ, Williams VC, Coker LD.
    J Clin Endocrinol Metab; 1990 May; 70(5):1312-8. PubMed ID: 2186058
    [Abstract] [Full Text] [Related]

  • 27. Increased circulating cholecystokinin contributes to anorexia and anxiety behavior in mice overexpressing pancreatic polypeptide.
    Ueno N, Asakawa A, Satoh Y, Inui A.
    Regul Pept; 2007 Jun 07; 141(1-3):8-11. PubMed ID: 17306894
    [Abstract] [Full Text] [Related]

  • 28. The effect of pancreatic denervation and atropine on the cholecystokinin-induced pancreatic exocrine response.
    Berry SM, Kuvshinoff BW, McFadden DW, Fink AS.
    Pancreas; 1996 Jan 07; 12(1):84-91. PubMed ID: 8927624
    [Abstract] [Full Text] [Related]

  • 29. Effect of L-364,718 on GRP-stimulated pancreatic and gastric secretions and GI peptides in conscious dogs.
    Hosotani R, Chowdhury P, Huang YS, McKay D, Yajima H, Rayford PL.
    Pancreas; 1989 Jan 07; 4(5):550-5. PubMed ID: 2813326
    [Abstract] [Full Text] [Related]

  • 30. Cholecystokinin receptors and vagal nerves in control of food intake in rats.
    Garlicki J, Konturek PK, Majka J, Kwiecien N, Konturek SJ.
    Am J Physiol; 1990 Jan 07; 258(1 Pt 1):E40-5. PubMed ID: 2301570
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Pancreatic polypeptide and peptide YY inhibit the denervated canine pancreas.
    DeMar AR, Taylor IL, Fink AS.
    Pancreas; 1991 Jul 07; 6(4):419-26. PubMed ID: 1876598
    [Abstract] [Full Text] [Related]

  • 33. Pancreatic polypeptide response to a meal before and after cutting the extrinsic nerves of the upper gastrointestinal tract and the pancreas in the dog.
    Niebel W, Eysselein VE, Singer MV.
    Dig Dis Sci; 1987 Sep 07; 32(9):1004-9. PubMed ID: 3622184
    [Abstract] [Full Text] [Related]

  • 34. CCK receptors in release of pancreatic polypeptide (PP) in dogs.
    Konturek SJ, Konturek P, Bielański W, Szewczyk K.
    Dig Dis Sci; 1989 Jun 07; 34(6):849-56. PubMed ID: 2721318
    [Abstract] [Full Text] [Related]

  • 35. Central versus peripheral effects of bombesin on the release of gastrointestinal hormones in dogs.
    Lu QH, Swierczek JS, Zhu XG, Greeley GH, Thompson JC.
    J Neurosci Res; 1986 Jun 07; 16(3):553-9. PubMed ID: 3772992
    [Abstract] [Full Text] [Related]

  • 36. Control of interdigestive and intraduodenal meal-stimulated pancreatic secretion in rats.
    Chariot J, Nagain C, Hugonet F, Tsocas A, Rozé C.
    Am J Physiol; 1990 Aug 07; 259(2 Pt 1):G198-204. PubMed ID: 1974389
    [Abstract] [Full Text] [Related]

  • 37. Cholecystokinin in the regulation of intestinal motility and pancreatic secretion in dogs.
    Thor P, Laskiewicz J, Konturek P, Konturek SJ.
    Am J Physiol; 1988 Oct 07; 255(4 Pt 1):G498-504. PubMed ID: 3177646
    [Abstract] [Full Text] [Related]

  • 38. Atropine and exocrine pancreatic secretion in alcohol-fed dogs.
    Tiscornia OM, Palasciano G, Sarles H.
    Am J Gastroenterol; 1975 Jan 07; 63(1):33-6. PubMed ID: 1119468
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. mu-Opiate receptor agonist loperamide blocks bethanechol-induced gallbladder contraction, despite higher cholecystokinin plasma levels in man.
    Otto B, Mawe GM, Riepl RL.
    Neurogastroenterol Motil; 2005 Oct 07; 17(5):761-6. PubMed ID: 16185316
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.